Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexaria Bioscience (LEXX) Inventory Average (2016 - 2023)

Historic Inventory Average for Lexaria Bioscience (LEXX) over the last 8 years, with Q1 2023 value amounting to $8762.0.

  • Lexaria Bioscience's Inventory Average fell 7024.43% to $8762.0 in Q1 2023 from the same period last year, while for Feb 2023 it was $8762.0, marking a year-over-year decrease of 7024.43%. This contributed to the annual value of $34033.0 for FY2022, which is 5354.46% down from last year.
  • According to the latest figures from Q1 2023, Lexaria Bioscience's Inventory Average is $8762.0, which was down 7024.43% from $24177.0 recorded in Q4 2022.
  • In the past 5 years, Lexaria Bioscience's Inventory Average registered a high of $157835.5 during Q3 2019, and its lowest value of $8762.0 during Q1 2023.
  • For the 5-year period, Lexaria Bioscience's Inventory Average averaged around $72874.7, with its median value being $55402.0 (2020).
  • Its Inventory Average has fluctuated over the past 5 years, first skyrocketed by 9282.56% in 2019, then plummeted by 7024.43% in 2023.
  • Over the past 5 years, Lexaria Bioscience's Inventory Average (Quarter) stood at $130476.0 in 2019, then tumbled by 57.54% to $55402.0 in 2020, then plummeted by 48.91% to $28307.0 in 2021, then dropped by 14.59% to $24177.0 in 2022, then crashed by 63.76% to $8762.0 in 2023.
  • Its Inventory Average was $8762.0 in Q1 2023, compared to $24177.0 in Q4 2022 and $39300.5 in Q3 2022.